Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neurodegenerative Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neurodegenerative Drugsmarket, defines the market attractiveness level of Neurodegenerative Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neurodegenerative Drugs industry, describes the types of Neurodegenerative Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neurodegenerative Drugs market and the development prospects and opportunities of Neurodegenerative Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neurodegenerative Drugs market in Chapter 13.
By Player:
Sanofi
Biogen Idec
Novartis
Pfizer
GlaxoSmithKline
Boehringer Ingelheim
TEVA Pharmaceuticals
UCB
Merck Serono
By Type:
N Methyl D Aspartate
Selective Serotonin Reuptake Inhibitors
Dopamine Inhibitors
By End-User:
Hospital
Research
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neurodegenerative Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neurodegenerative Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neurodegenerative Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neurodegenerative Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neurodegenerative Drugs Market Analysis and Outlook to 2022
-
7.1 Global Neurodegenerative Drugs Consumption (2017-2022)
-
7.2 United States Neurodegenerative Drugs Consumption (2017-2022)
-
7.3 Europe Neurodegenerative Drugs Consumption (2017-2022)
-
7.4 China Neurodegenerative Drugs Consumption (2017-2022)
-
7.5 Japan Neurodegenerative Drugs Consumption (2017-2022)
-
7.6 India Neurodegenerative Drugs Consumption (2017-2022)
-
7.7 South Korea Neurodegenerative Drugs Consumption (2017-2022)
8 Region and Country-wise Neurodegenerative Drugs Market Analysis and Outlook to 2028
-
8.1 Global Neurodegenerative Drugs Consumption Forecast (2022-2028)
-
8.2 United States Neurodegenerative Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Neurodegenerative Drugs Consumption Forecast (2022-2028)
-
8.4 China Neurodegenerative Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Neurodegenerative Drugs Consumption Forecast (2022-2028)
-
8.6 India Neurodegenerative Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Neurodegenerative Drugs Consumption Forecast (2022-2028)
9 Global Neurodegenerative Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Neurodegenerative Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global N Methyl D Aspartate Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Selective Serotonin Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dopamine Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Neurodegenerative Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Consumption and Growth Rate (2017-2022)
10 Global Neurodegenerative Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Neurodegenerative Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global N Methyl D Aspartate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Selective Serotonin Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dopamine Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neurodegenerative Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Consumption Forecast and Growth Rate (2022-2028)
11 Global Neurodegenerative Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neurodegenerative Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neurodegenerative Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neurodegenerative Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neurodegenerative Drugs Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Neurodegenerative Drugs Product and Service
-
14.2 Biogen Idec
-
14.2.1 Biogen Idec Company Details
-
14.2.2 Biogen Idec Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Biogen Idec Neurodegenerative Drugs Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Neurodegenerative Drugs Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Neurodegenerative Drugs Product and Service
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Details
-
14.5.2 GlaxoSmithKline Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Neurodegenerative Drugs Product and Service
-
14.6 Boehringer Ingelheim
-
14.6.1 Boehringer Ingelheim Company Details
-
14.6.2 Boehringer Ingelheim Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Boehringer Ingelheim Neurodegenerative Drugs Product and Service
-
14.7 TEVA Pharmaceuticals
-
14.7.1 TEVA Pharmaceuticals Company Details
-
14.7.2 TEVA Pharmaceuticals Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 TEVA Pharmaceuticals Neurodegenerative Drugs Product and Service
-
14.8 UCB
-
14.8.1 UCB Company Details
-
14.8.2 UCB Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 UCB Neurodegenerative Drugs Product and Service
-
14.9 Merck Serono
-
14.9.1 Merck Serono Company Details
-
14.9.2 Merck Serono Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Serono Neurodegenerative Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neurodegenerative Drugs
-
Figure Neurodegenerative Drugs Picture
-
Table Global Neurodegenerative Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurodegenerative Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurodegenerative Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neurodegenerative Drugs Consumption by Country (2017-2022)
-
Figure United States Neurodegenerative Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Neurodegenerative Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Neurodegenerative Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Neurodegenerative Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Neurodegenerative Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neurodegenerative Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Neurodegenerative Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Neurodegenerative Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neurodegenerative Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neurodegenerative Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neurodegenerative Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neurodegenerative Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neurodegenerative Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global N Methyl D Aspartate Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Serotonin Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Dopamine Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Research Consumption and Growth Rate (2017-2022)
-
Figure Global N Methyl D Aspartate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Serotonin Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dopamine Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neurodegenerative Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neurodegenerative Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Neurodegenerative Drugs Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Neurodegenerative Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Neurodegenerative Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neurodegenerative Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Neurodegenerative Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Neurodegenerative Drugs Product and Service
-
Table TEVA Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table TEVA Pharmaceuticals Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Pharmaceuticals Neurodegenerative Drugs Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Neurodegenerative Drugs Product and Service
-
Table Merck Serono (Foundation Year, Company Profile and etc.)
-
Table Merck Serono Neurodegenerative Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Serono Neurodegenerative Drugs Product and Service
-
